Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast CancerKimberly Blackwell, Joyce O’Shaughnessy|Journal of Clinical Oncology|2010Cited by 960
Breast Carcinomas Arising at a Young Age: Unique Biology or a Surrogate for Aggressive Intrinsic Subtypes?Carey K. Anders, Charles M. Perou, Cheng Fan et al.|Journal of Clinical Oncology|2010Cited by 269
<i>PIK3CA</i> mutations enable targeting of a breast tumor dependency through mTOR-mediated MCL-1 translationGrace R. Anderson, Kris C. Wood, Jim C. Leeds et al.|Science Translational Medicine|2016Cited by 58